Titlebook: Non-Hodgkin Lymphoma; Pathology, Imaging, Andrew M. Evens,Kristie A. Blum Book 2015 Springer International Publishing Switzerland 2015 Epi

尖酸好

書目名稱Non-Hodgkin Lymphoma影響因子(影響力)




書目名稱Non-Hodgkin Lymphoma影響因子(影響力)學科排名




書目名稱Non-Hodgkin Lymphoma網(wǎng)絡公開度




書目名稱Non-Hodgkin Lymphoma網(wǎng)絡公開度學科排名




書目名稱Non-Hodgkin Lymphoma被引頻次




書目名稱Non-Hodgkin Lymphoma被引頻次學科排名




書目名稱Non-Hodgkin Lymphoma年度引用




書目名稱Non-Hodgkin Lymphoma年度引用學科排名




書目名稱Non-Hodgkin Lymphoma讀者反饋




書目名稱Non-Hodgkin Lymphoma讀者反饋學科排名

初學者

Book 2015in lymphoma, taking into account the significant growth in knowledge including multiple therapeutic advances that have been achieved over the past 5-10 years. The work is subdivided into epidemiology, pathogenesis, pathology, imaging, and therapy of the non-Hodgkin lymphomas. The full range of thera

municipality

Epidemiology and Etiology of Non-Hodgkin Lymphoma,of lymphomagenesis, but significant etiologic heterogeneity clearly exists. This review presents a summary of the current understanding of the descriptive epidemiology and etiology of NHL and suggests areas of focus for future epidemiologic research.

callous

PATRI

拍翅

Current Management of Peripheral T-Cell Lymphomas,rs, aurora kinase inhibitors and the CD30 antibody-drug conjugate brentuximab vedotin, have shown promise in the treatment of PTCLs. Studies are underway to explore the activity of these newer agents used in the frontline setting.

Congregate

Book 2015peutic options are examined according to the major subtypes of non-Hodgkin lymphoma and the most up-to-date information is provided on current standard treatment options, including stem cell transplantation as well as new cutting-edge therapeutics.

CLEAR

說笑

Airtight